Table 5.

Independent Predictors for Symptom Reports (Period Prevalence) as Determined by Nominal Logistic Regression

	Full model
Symptom	Log likelihood ratio	χ2	p	PPV	NPV	Predictor	Parameter estimate	χ2	p	OR	Lower 95% CI limit	Upper 95% CI Limit
Restlessness	5.89	11.71	0.003	0.50	0.73	Outpatient (baseline)	0.33	4.73	0.041	1.95	0.28	0.94
						Age	0.08	4.18	0.030	1.08	1.05	11.9
Psychomotor activation	40.43	80.86	<0.0001	0.74	0.87	Stimulant (comedication)	1.07	21.79	<0.0001	8.49	3.53	21.47
						Age	0.23	19.69	<0.0001	1.26	1.14	1.41
						Outpatient (baseline)	0.94	17.53	<0.0001	6.60	2.79	16.48
						CGAS (baseline)	0.10	12.23	0.0005	1.10	1.16	0.91
Drowsiness	7.06	14.11	0.0009	0.85	1	Age	−0.117	5.91	0.015	0.81	0.98	1.12
						CGAS (baseline)	0.057	5.65	0.017	1.01	1.11	0.94
Psychomotor retardation	33.99	67.98	<0.0001	0.64	0.82	Diagnosis: schizophrenia-spectrum disorders	0.989	6.05	0.014	vs. Aggression 8.1	2.51	31.89
						CGAS (baseline)	0.054	6.02	0.014	1.05	1.01	1.10
						Age	−0.137	5.11	0.024	0.87	0.76	0.98
						Female	−0.364	4.19	0.041	0.48	0.24	0.96
						Aripiprazole	−0.646	3.71	0.054	vs. RIS 0.28	0.11	0.72

CGAS, Children's Global Assessment scale; CI, confidence interval; NPV, negative predictive value; OR, odds ratio; per unit increase for continuous variables; PPV, positive predictive value; RIS, risperidone.